Most Popular Articles : Journal of Immunotherapy

Secondary Logo

Journal Logo

Most Popular Articles

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment

Diem, Stefan; Fässler, Mirjam; Bomze, David; More

Journal of Immunotherapy. 42(3):89-93, April 2019.

Cytokine Maturation Followed by CD40L mRNA Electroporation Results in a Clinically Relevant Dendritic Cell Product Capable of Inducing a Potent Proinflammatory CTL Response

Calderhead, David M.; DeBenedette, Mark A.; Ketteringham, Helen; More

Journal of Immunotherapy. 31(8):731-741, October 2008.

Laser Interstitial Thermal Therapy Induces Robust Local Immune Response for Newly Diagnosed Glioblastoma with Long-term Survival and Disease Control

Chandar, Jay S.; Bhatia, Shovan; Ingle, Shreya; More

Journal of Immunotherapy. : September 19, 2023

Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands

van Zeijl, Michiel C.T.; van Breeschoten, Jesper; de Wreede, Liesbeth C.; More

Journal of Immunotherapy. 46(5):197-204, June 2023.

Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma

Wilgenhof, Sofie; Van Nuffel, An M.T.; Corthals, Jurgen; More

Journal of Immunotherapy. 34(5):448-456, June 2011.

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Morgan, Richard A.; Chinnasamy, Nachimuthu; Abate-Daga, Daniel; More

Journal of Immunotherapy. 36(2):133-151, February-March 2013.

Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer

Nishida, Sumiyuki; Koido, Shigeo; Takeda, Yutaka; More

Journal of Immunotherapy. 37(2):105-114, February/March 2014.

Construction and Evaluation of Clinical Prediction Model for Immunotherapy-related Adverse Events and Clinical Benefit in Cancer Patients Receiving Immune Checkpoint Inhibitors Based on Serum Cytokine Levels

Zhao, Ni; Jiang, Aimin; Shang, Xiao; More

Journal of Immunotherapy. 46(8):310-322, October 2023.

The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors: Evaluation of Four Different scFvs and Antigens

Guest, Ryan D; Hawkins, Robert E; Kirillova, Natalia; More

Journal of Immunotherapy. 28(3):203-211, May-June 2005.

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib

Qin, Jim S.; Johnstone, Timothy G.; Baturevych, Alex; More

Journal of Immunotherapy. 43(4):107-120, May 2020.

Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8α

Anderson, Victoria E.; Brilha, Sara S.; Weber, Anika M.; More

Journal of Immunotherapy. 46(4):132-144, May 2023.

Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity

Fotin-Mleczek, Mariola; Duchardt, Katharina M.; Lorenz, Christina; More

Journal of Immunotherapy. 34(1):1-15, January 2011.

Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model

Teng, Ruidi; Zhao, Jingjing; Zhao, Yiding; More

Journal of Immunotherapy. 42(2):33-42, February/March 2019.

Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid Cells

Salem, Mohamed L.; Kadima, Andre N.; EL-Naggar, Sabry A.; More

Journal of Immunotherapy. 30(1):40-53, January 2007.

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells

Shrestha, Bishwas; Zhang, Yongliang; Yu, Bin; More

Journal of Immunotherapy. 43(3):79-88, April 2020.

Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy

Hollyman, Daniel; Stefanski, Jolanta; Przybylowski, Mark; More

Journal of Immunotherapy. 32(2):169-180, February-March 2009.

Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study

Hendriks, Natasja; Koeneman, Margot M.; van de Sande, Anna J.M.; More

Journal of Immunotherapy. 45(3):180-186, April 2022.

Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non–Small Cell Lung Cancer After Nivolumab Therapy

Karayama, Masato; Inoue, Yusuke; Yoshimura, Katsuhiro; More

Journal of Immunotherapy. 45(2):125-131, February/March 2022.

Long-term Overall Survival and Predictors in Anti–PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort Study

Naik, Girish S.; Buchbinder, Elizabeth I.; Cohen, Justine V.; More

Journal of Immunotherapy. 44(8):307-318, October 2021.

Association of Baseline and Pharmacodynamic Biomarkers With Outcomes in Patients Treated With the PD-1 Inhibitor Budigalimab

Lambert, Stacie L.; Zhang, Chun; Guo, Claire; More

Journal of Immunotherapy. 45(3):167-179, April 2022.

Cancer and Inflammation: Promise for Biologic Therapy

Demaria, Sandra; Pikarsky, Eli; Karin, Michael; More

Journal of Immunotherapy. 33(4):335-351, May 2010.

Activation and Propagation of Tumor-infiltrating Lymphocytes on Clinical-grade Designer Artificial Antigen-presenting Cells for Adoptive Immunotherapy of Melanoma

Forget, Marie-Andrée; Malu, Shruti; Liu, Hui; More

Journal of Immunotherapy. 37(9):448-460, November/December 2014.

Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy

Itzhaki, Orit; Hovav, Einat; Ziporen, Yaara; More

Journal of Immunotherapy. 34(2):212-220, March 2011.

Identification of a Promiscuous Epitope Peptide Derived From HSP70

Matsui, Hiroto; Hazama, Shoichi; Tamada, Koji; More

Journal of Immunotherapy. 42(7):244-250, September 2019.

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

Wang, Xueyin; Sandberg, Mark L.; Martin, Aaron D.; More

Journal of Immunotherapy. 44(8):292-306, October 2021.

Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB

Dudal, Sherri; Hinton, Heather; Giusti, Anna M.; More

Journal of Immunotherapy. 39(7):279-289, September 2016.

CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma

de Vos, Luka; Carrillo Cano, Tzaitel Maria; Zarbl, Romina; More

Journal of Immunotherapy. 45(7):324-334, September 2022.

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

Lam, Elaine T.; Wong, Michael K. K.; Agarwal, Neeraj; More

Journal of Immunotherapy. 37(7):360-365, September 2014.